Table 2.
Patient laboratory findings at pneumonia diagnosis.
| MV group (N = 8) | non-MV group (N = 15) |
P- value | ||||
|---|---|---|---|---|---|---|
| WBC,/μL | Median (range) | 4850.0 | (2900.0–9900.0) | 4500.0 | (2300.0–8200.0) | 0.418 |
| Neut,/μL | Median (range) | 3638.2 | (2130.0–9434.7) | 3066.0 | (1150.0–4544.1) | 0.302 |
| Lymph,/μL | Median (range) | 768.0 | (366.3–1702.4) | 959.1 | (423.3–3632.6) | 0.333 |
| Hb, g/dL | Median (range) | 15.05 | (11.8–16.9) | 15.3 | (11.5–17.4) | 0.923 |
| Plt, × 105/μL | Median (range) | 11.45 | (9.7–16.9) | 17.0 | (5.0–25.2) | 0.020 |
| CRP, mg/dL | Median (range) | 7.54 | (0.95–34.43) | 2.55 | (0.05–7.94) | 0.028 |
| LDH, U/L | Median (range) | 383.0 | (217–782) | 240.0 | (154–824) | 0.008 |
| KL-6a, U/mL | Median (range) | 337.0 | (212–520) | 230.5 | (151–729) | 0.351 |
| Ferritinb, ng/mL | Median (range) | 1534.0 | (635.1–3070.0) | 452.0 | (186.3–1134) | 0.009 |
| sIL-2Rc, U/mL | Median (range) | 465.0 | (354.9–1648.0) | 772.0 | (410–1155) | 0.855 |
| PCT, ng/mL | Median (range) | 0.11 | (0.09–0.89) | 0.06 | (0.02–1.06) | 0.035 |
| BUN, mg/dL | Median (range) | 15.85 | (6.4–28) | 12.70 | (6.6–71.7) | 0.333 |
| Cr, mg/dL | Median (range) | 0.97 | (0.74–1.37) | 0.74 | (0.51–1.34) | 0.018 |
| AST, U/L | Median (range) | 47.5 | (25–213) | 24 | (16–145) | 0.011 |
| ALT, U/L | Median (range) | 41.5 | (19–267) | 20 | (12–55) | 0.030 |
| Alb, g/dL | Median (range) | 3.6 | (2.9–4.4) | 3.9 | (2.8–4.8) | 0.419 |
| D-dimer, μg/mL | Median (range) | 1.6 | (0.9–2.5) | 1.0 | (0.7–2.9) | 0.038 |
MV; mechanical ventilation, WBC; white blood cells, Neut; neutrophils, Lymph; lymphocytes, Hb; hemoglobin, Plt; platelets, CRP; C-reactive protein, LDH; lactase dehydrogenase, KL-6; Krebs von den Lungen-6, sIL-2R; soluble interleukin-2 receptor, PCT; procalcitonin, BUN; blood urea nitrogen, Cr; creatinine, AST; aspartate aminotransferase, ALT; alanine aminotransferase, Alb; albumin.
a
Two patients were not evaluated for KL-6.
b
Nine patients were not evaluated for ferritin.
c
Twelve patients were not evaluated for sIL-2R.